Indians can expect to get their first COVID-19 vaccine shot on January 13. Union Health Ministry announced on Tuesday that the Centre is all set to roll out coronavirus vaccines within 10 days of granting emergency use approval. The announcement by the ministry comes just days after the DCGI approved...
Tamil Nadu health minister C Vijayabaskar voluntarily took the vaccine Covaxin at Rajiv Gandhi Government General Hospital in Chennai. Vijayabaskar, who is a doctor and a member of the IMA, had earlier said that he was taking the vaccine to instill confidence in the people about the vaccine. Opposition parties have been raising concerns about the efficacy of Covaxin. ‘I got my covaxin shot! Thanks to the team @gmcrgggh for the seamless experience. Appeal everyone to do it when your turn comes. Let's end #Covid19 together,’ Vijayabaskar tweeted after getting the jab. India launched the world’s biggest vaccination drive on 16th of January, 2021 after two vaccines were given approval by authorities. Watch the full video for all the details.
Credit: HT Digital Content Duration: 02:14Published
Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India. ‘Government should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said. The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved. The first phase of coronavirus vaccination is all set to begin on 16th January, 2021. Watch the full video for all the details.
Credit: HT Digital Content Duration: 01:40Published
The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government. Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII). Around 30 crore people are being targeted for vaccination in phase 1. These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities. Watch the full video for more.
Credit: HT Digital Content Duration: 01:34Published
ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine which is manufactured at Pune’s Serum Institute of India (SII). Covishield was the first vaccine in India to get the DCGI nod. Soon after, DCGI approved Covaxin. Watch the full video for more details.
Credit: HT Digital Content Duration: 04:32Published
The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.
India dispatched consignments of SII's Covishield to Myanmar, Seychelles and Mauritius. India is sending Covid-19 vaccines as part of donation program to neighbours and key partners. Bhutan, Maldives, Bangladesh, Nepal were also part of India's initial rollout of vaccines. In addition, India plans to supply vaccine doses to Afghanistan and Sri Lanka. Covishield's commercial supplies to countries having agreements with SII have also begun. Two flights are slated to carry two million doses each to Brazil and Morocco on Friday. India is carrying out vaccine diplomacy under its 'Neighbourhood First' policy. Last week, India launched the world's biggest Covid-19 vaccination drive across the country.
Credit: HT Digital Content Duration: 02:46Published
Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 22. The consignment containing COVID-19 vaccine will be dispatched to Myanmar, Seychelles and Mauritius.